UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combined Mitral and Aortic Valve Surgery: 17-year Experience in a Single Center

Scandinavian journal of surgery, 2021-12, Vol.110 (4), p.533-541

2021

Volltextzugriff (PDF)

ASO Visual Abstract: Postoperative Complications After Neoadjuvant Chemotherapy Compared with Upfront Surgery in Gastric Adenocarcinoma—A Population-Based, Nationwide Study in Finland

ANNALS OF SURGICAL ONCOLOGY, 2024-05, Vol.31 (5), p.3040-3041

2024

Volltextzugriff (PDF)

Early and late pace‐maker implantation after transcatheter and surgical aortic valve replacement

Catheterization and cardiovascular interventions, 2021-03, Vol.97 (4), p.E560-E568

2021

Volltextzugriff (PDF)

TCT-805 Impact of Major Vascular Complications on Outcome Following Transfemoral Transcatheter Aortic Valve Replacement

Journal of the American College of Cardiology, 2019-10, Vol.74 (13), p.B789-B789

2019

Volltextzugriff (PDF)

Abstract 14571: Prospective Randomized Comparisonof Miniaturized Extracorporeal Circulation System (MECC) versus Conventional Extracorporeal Circulation System (cecc) in the Prevention of Postoperative Atrial Fibrillation (FA) and Other Clinical Results in Cardiac Surgery Patients

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A14571-A14571

2015

Volltextzugriff (PDF)

Mixed Venous Oxygen Saturation during the Transcatheter Aortic Valve Replacement—A Prospective Cohort Study

Open Journal of Anesthesiology (Irvine, CA), 2019, Vol.9 (7), p.140-153

2019

Volltextzugriff (PDF)

Impact of Major Vascular Complication Access Site Status on Mortality After Transfemoral Transcatheter Aortic Valve Replacement　― Results From the FinnValve Registry

Circulation Reports, 2020/03/10, Vol.2(3), pp.182-191

2020

Volltextzugriff (PDF)

Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study

PloS one, 2020-01, Vol.15 (9), p.e0238953

2020

Volltextzugriff (PDF)

Start age of enzyme replacement therapy (ERT) did not effect ECG parameters in Fabry disease patients (FD) treated by ERT for 5 years

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107176, Article 107176

2023

Volltextzugriff (PDF)

PQ interval, QRS duration and QTc interval increased in Fabry disease patients treated by enzyme replacement therapy both for 10 and 15 years

Molecular genetics and metabolism, 2020-02, Vol.129 (2), p.S83-S83

2020

Volltextzugriff (PDF)

Factors Affecting Early Immune Recovery after Autologous Transplantation and Its Clinical Significance - a Prospective Analysis of Patients with Non-Hodgkin Lymphoma

Blood, 2015-12, Vol.126 (23), p.3199-3199

2015

Volltextzugriff (PDF)

Deterioration in ECG parameters in Fabry females and males treated by enzyme replacement therapy either for 5 or 10 years

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S74-S74

2018

Volltextzugriff (PDF)

Enzyme replacement therapy together with renin-angiotensin system inhibition seems to prevent kidney function decrease in most Finnish Fabry patients treated either for 5 or 10 years

Molecular genetics and metabolism, 2019-02, Vol.126 (2), p.S81-S82

2019

Volltextzugriff (PDF)

Stem Cell Graft Cellular Composition, Hematological and Immune Recovery in NHL Patients Mobilized with or without Plerixafor: A Prospective Comparison

Blood, 2014-12, Vol.124 (21), p.1193-1193

2014

Volltextzugriff (PDF)

PQ-interval and QRS duration increased in Fabry patients treated by enzyme replacement therapy for 12 years

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.S73-S74

2017

Volltextzugriff (PDF)

Enzyme replacement therapy carries for 4-7 years in Fabry disease thereafter quality of life decreases

Molecular genetics and metabolism, 2016-02, Vol.117 (2), p.S64-S64

2016

Volltextzugriff (PDF)

Enzyme replacement therapy carries for 4-7years in Fabry disease thereafter quality of life decreases

Molecular genetics and metabolism, 2016-02, Vol.117 (2), p.S64

2016

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Thema

Aortic Valve
(2)
Bleeding
(2)
Complications
(2)
Major Vascular Complication
(2)
Prognosis
(2)
Transfemoral Transcatheter Aortic Valve Replacement
(2)
Adenocarcinoma
(1)
Aortic
(1)
Aortic Valve - Surgery
(1)
Aortic Valve Replacement
(1)
Aortic Valve Stenosis
(1)
Aso Visual Abstract
(1)
Cardiac Surgery
(1)
Cardiology
(1)
Cardiothoracic Surgery
(1)
Catheters
(1)
Chemotherapy
(1)
Constriction, Pathologic
(1)
Defibrillators
(1)
Endocarditis
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combined Mitral and Aortic Valve Surgery: 17-year Experience in a Single Center

ASO Visual Abstract: Postoperative Complications After Neoadjuvant Chemotherapy Compared with Upfront Surgery in Gastric Adenocarcinoma—A Population-Based, Nationwide Study in Finland

Early and late pace‐maker implantation after transcatheter and surgical aortic valve replacement

TCT-805 Impact of Major Vascular Complications on Outcome Following Transfemoral Transcatheter Aortic Valve Replacement

Abstract 14571: Prospective Randomized Comparisonof Miniaturized Extracorporeal Circulation System (MECC) versus Conventional Extracorporeal Circulation System (cecc) in the Prevention of Postoperative Atrial Fibrillation (FA) and Other Clinical Results in Cardiac Surgery Patients

Mixed Venous Oxygen Saturation during the Transcatheter Aortic Valve Replacement—A Prospective Cohort Study

Impact of Major Vascular Complication Access Site Status on Mortality After Transfemoral Transcatheter Aortic Valve Replacement　― Results From the FinnValve Registry

Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study

Impact of Major Vascular Complication Access Site Status on Mortality After Transfemoral Transcatheter Aortic Valve Replacement　― Results From the FinnValve Registry

Start age of enzyme replacement therapy (ERT) did not effect ECG parameters in Fabry disease patients (FD) treated by ERT for 5 years

PQ interval, QRS duration and QTc interval increased in Fabry disease patients treated by enzyme replacement therapy both for 10 and 15 years

Factors Affecting Early Immune Recovery after Autologous Transplantation and Its Clinical Significance - a Prospective Analysis of Patients with Non-Hodgkin Lymphoma

Deterioration in ECG parameters in Fabry females and males treated by enzyme replacement therapy either for 5 or 10 years

Enzyme replacement therapy together with renin-angiotensin system inhibition seems to prevent kidney function decrease in most Finnish Fabry patients treated either for 5 or 10 years

Stem Cell Graft Cellular Composition, Hematological and Immune Recovery in NHL Patients Mobilized with or without Plerixafor: A Prospective Comparison

PQ-interval and QRS duration increased in Fabry patients treated by enzyme replacement therapy for 12 years

Enzyme replacement therapy carries for 4-7 years in Fabry disease thereafter quality of life decreases

Enzyme replacement therapy carries for 4-7years in Fabry disease thereafter quality of life decreases

Aktive Filter

Suchergebnisse filtern